# ZNTL (Zentalis Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Zentalis Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $141.7M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/ZNTL
- Markdown: https://convexityos.com/fundamentals/ZNTL.md
- SEC CIK: 0001725160
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:45 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001725160&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$150.8M | Operating profit |
| Net Income | FY 2025 | -$141.7M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.67 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$133.9M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $228.9M | Total debt: $36.71M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $67.42M | $0 | $0 | -- | -- | -- |
| Research & Development | $107.3M | $167.8M | $189.6M | $172.7M | $175.6M | $84.90M | $38.39M |
| Total Operating Expenses | $152.8M | $258.6M | $299.5M | $227.3M | $216.5M | $118.8M | $46.84M |
| **Operating Income** | -$152.8M | -$191.2M | -$299.5M | -$227.3M | -$216.5M | -$118.8M | -$46.84M |
| **EBITDA** | -$152.1M | -$189.9M | -$298.1M | -$225.9M | -$216.0M | -$118.6M | -$46.73M |
| Income Before Tax | -$136.6M | -$165.7M | -$292.9M | -$237.6M | -$166.4M | -$118.1M | -$46.36M |
| Income Tax Expense | $442K | $177K | -$601K | -$469K | -$297K | $444K | $15K |
| **Net Income** | -$137.1M | -$165.8M | -$292.2M | -$236.8M | -$158.7M | -$117.8M | -$45.66M |
| Basic EPS | -$1.91 | -$2.33 | -$4.47 | -$4.48 | -$3.72 | -$4.19 | -- |
| **Diluted EPS** | -$1.91 | -$2.33 | -$4.47 | -$4.48 | -$3.72 | -$4.19 | -$8.16 |
| Basic Shares Outstanding | 71.9M | 71.1M | 65.4M | 52.9M | 42.7M | 28.1M | 5.6M |
| Diluted Shares Outstanding | 71.9M | 71.1M | 65.4M | 52.9M | 42.7M | 28.1M | 5.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $0 | $26.86M |
| Research & Development | $22.33M | $35.16M | $28.72M | $29.49M | $22.95M | $27.61M | $27.25M | $32.97M |
| Total Operating Expenses | $31.15M | $44.39M | $37.85M | $37.39M | $33.73M | $36.06M | $45.62M | $76.71M |
| **Operating Income** | -$31.15M | -$44.39M | -$37.85M | -$37.39M | -$33.73M | -$36.06M | -$45.62M | -$49.85M |
| **EBITDA** | -$31.00M | -$44.24M | -$37.70M | -$37.24M | -$33.57M | -$35.90M | -$45.36M | -$49.53M |
| Income Before Tax | -$28.70M | -$42.15M | -$35.23M | -$34.77M | -$26.69M | -$26.87M | -$48.28M | -$47.68M |
| Income Tax Expense | $118K | $138K | $120K | $442K | $0 | $0 | $0 | -$205K |
| **Net Income** | -$28.82M | -$42.29M | -$35.35M | -$35.22M | -$26.69M | -$26.87M | -$48.28M | -$47.47M |
| Basic EPS | -$0.34 | -$0.59 | -$0.50 | -- | -$0.37 | -$0.37 | -$0.67 | -- |
| **Diluted EPS** | -$0.34 | -$0.59 | -$0.50 | -- | -$0.37 | -$0.37 | -$0.67 | -- |
| Basic Shares Outstanding | 84.6M | 71.3M | 70.3M | -- | 72.1M | 72.0M | 71.7M | -- |
| Diluted Shares Outstanding | 84.6M | 71.3M | 70.3M | -- | 72.1M | 72.0M | 71.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.99M | $33.90M | $28.04M | $43.07M | $59.71M | $54.95M | $67.25M |
| Short-Term Investments | $209.9M | $318.0M | $454.9M | -- | -- | $283.6M | -- |
| **Cash & Short-Term Investments** | $245.9M | $351.9M | $482.9M | $43.07M | $59.71M | $338.5M | $67.25M |
| Accounts Receivable, Net | $0 | $5.00M | $0 | -- | $4.0K | $417K | $140K |
| **Total Current Assets** | $253.2M | $386.1M | $496.7M | $451.9M | $350.8M | $345.1M | $68.89M |
| Property, Plant & Equipment, Net | $2.77M | $4.70M | $5.82M | $7.71M | $8.15M | $1.10M | $501K |
| Goodwill | -- | $0 | $3.74M | $3.74M | $3.74M | $3.74M | $3.74M |
| Intangible Assets | -- | -- | -- | -- | -- | $8.80M | -- |
| **Total Non-Current Assets** | $35.78M | $44.27M | $54.97M | $87.38M | $103.7M | $20.45M | $18.59M |
| **Total Assets** | $289.0M | $430.3M | $551.7M | $539.3M | $454.5M | $365.6M | $87.48M |
| Accounts Payable | $7.21M | $7.44M | $14.93M | $11.25M | $11.59M | $8.66M | $4.29M |
| **Total Current Liabilities** | $36.56M | $52.73M | $69.37M | $56.65M | $43.94M | $28.60M | $14.90M |
| Other Non-Current Liabilities | $500K | $849K | $1.78M | $2.62M | $0 | $1.10M | $1.70M |
| **Total Non-Current Liabilities** | $36.20M | $40.43M | $44.93M | $48.64M | $46.08M | $3.58M | $4.16M |
| **Total Liabilities** | $72.76M | $93.15M | $114.3M | $105.3M | $90.03M | $32.18M | $19.06M |
| **Total Debt (incl. Leases)** | $39.58M | $42.65M | $45.77M | $47.33M | $45.91M | $2.00M | $781K |
| Common Stock | $69K | $71K | $70K | $59K | $45K | $41K | $0 |
| Retained Earnings | -$1.19B | -$1.05B | -$888.6M | -$596.4M | -$359.6M | -$200.8M | -$82.99M |
| Accumulated Other Comp. Income | $196K | $558K | $2.19M | -$1.35M | -$125K | $36K | $0 |
| **Total Stockholders' Equity** | $216.2M | $337.2M | $437.3M | $433.8M | $364.0M | $308.6M | -- |
| Total Equity | $216.2M | $337.2M | $437.4M | $434.0M | $364.5M | $333.4M | -$73.28M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $24.03M | $24.78M | $31.93M | $35.99M | $39.07M | $37.60M | $41.93M | $33.90M |
| Short-Term Investments | $204.9M | $149.8M | $179.8M | $209.9M | $239.2M | $249.0M | $278.4M | $318.0M |
| **Cash & Short-Term Investments** | $228.9M | $174.6M | $211.8M | $245.9M | $278.3M | $286.6M | $320.3M | $351.9M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $5.00M |
| **Total Current Assets** | $237.3M | $181.3M | $218.1M | $253.2M | $288.3M | $311.6M | $342.9M | $386.1M |
| Property, Plant & Equipment, Net | $2.35M | $2.50M | $2.65M | $2.77M | $2.93M | $3.09M | $3.25M | $4.70M |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $32.92M | $34.05M | $34.97M | $35.78M | $38.95M | $40.11M | $41.14M | $44.27M |
| **Total Assets** | $270.2M | $215.3M | $253.1M | $289.0M | $327.2M | $351.7M | $384.0M | $430.3M |
| Accounts Payable | $5.33M | $8.14M | $7.38M | $7.21M | $7.03M | $3.72M | $7.77M | $7.44M |
| **Total Current Liabilities** | $32.36M | $37.63M | $35.24M | $36.56M | $37.17M | $39.02M | $49.43M | $52.73M |
| Other Non-Current Liabilities | $500K | $500K | $500K | $500K | $500K | $500K | $558K | $849K |
| **Total Non-Current Liabilities** | $32.94M | $34.06M | $35.15M | $36.20M | $37.21M | $38.19M | $39.21M | $40.43M |
| **Total Liabilities** | $65.31M | $71.68M | $70.39M | $72.76M | $74.38M | $77.21M | $88.64M | $93.15M |
| **Total Debt (incl. Leases)** | $36.71M | $37.69M | $38.65M | $39.58M | $40.46M | $41.32M | $42.16M | $42.65M |
| Common Stock | $98K | $72K | $71K | $69K | $72K | $72K | $72K | $71K |
| Retained Earnings | -$1.30B | -$1.27B | -$1.23B | -$1.19B | -$1.16B | -$1.13B | -$1.10B | -$1.05B |
| Accumulated Other Comp. Income | -$495K | -$78K | -$50K | $196K | $186K | $59K | $358K | $558K |
| **Total Stockholders' Equity** | $204.9M | $143.6M | $182.7M | $216.2M | $252.9M | $274.5M | $295.4M | $337.2M |
| Total Equity | $204.9M | $143.6M | $182.7M | $216.2M | $252.9M | $274.5M | $295.4M | $337.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$137.1M | -$165.9M | -$292.3M | -$237.1M | -$166.1M | -$118.5M | -$46.38M |
| Depreciation & Amortization | $739K | $1.29M | $1.39M | $1.43M | $544K | $160K | $111K |
| Stock-Based Compensation | $20.72M | $67.27M | $54.82M | $46.84M | $35.74M | $23.15M | $617K |
| Change in Receivables | $5.00M | -$5.00M | $0 | $0 | $413K | -$277K | $777K |
| **Operating Cash Flow** | -$125.2M | -$170.9M | -$207.8M | -$163.8M | -$154.1M | -$86.83M | -$39.14M |
| Capital Expenditure | $0 | -$221K | -$583K | -$2.55M | -$6.11M | -$758K | -$352K |
| **Free Cash Flow** | -$125.2M | -$171.1M | -$208.4M | -$166.3M | -$160.2M | -$87.58M | -$39.49M |
| Purchases of Investments | -$139.5M | -$128.0M | -$549.2M | -$533.2M | -$363.5M | -$401.0M | $0 |
| **Investing Cash Flow** | $131.6M | $176.6M | -$44.46M | -$114.2M | -$18.11M | -$284.8M | -$352K |
| Common Stock Issued | $5.39M | $0 | $235.7M | $257.9M | $172.0M | $155.3M | $0 |
| Share Repurchases | -$9.98M | $0 | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | -$4.28M | $108K | $237.3M | $261.0M | $178.5M | $360.4M | $81.83M |
| **Net Change in Cash** | $2.09M | $5.81M | -$14.98M | -$16.89M | $6.31M | -$11.22M | $42.34M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.82M | -$42.29M | -$35.35M | -$35.22M | -$26.69M | -$26.87M | -$48.28M | -$47.47M |
| Depreciation & Amortization | $152K | $152K | $151K | $157K | $160K | $160K | $262K | $317K |
| Stock-Based Compensation | $3.21M | $3.21M | $3.20M | $3.12M | $4.83M | $6.29M | $6.49M | $31.36M |
| Change in Receivables | $0 | $0 | $0 | -- | $0 | $0 | $5.00M | -- |
| **Operating Cash Flow** | -$32.71M | -$37.24M | -$32.96M | -$30.94M | -$26.96M | -$34.71M | -$32.64M | -$39.70M |
| Capital Expenditure | $0 | $0 | -$34K | $0 | $0 | $0 | $0 | $0 |
| **Free Cash Flow** | -$32.71M | -$37.24M | -$32.99M | -$30.94M | -$26.96M | -$34.71M | -$32.64M | -$39.70M |
| Purchases of Investments | -$115.3M | -$29.98M | -$29.95M | -$30.24M | -$49.53M | -$40.19M | -$19.53M | -$39.22M |
| **Investing Cash Flow** | -$55.31M | $30.02M | $30.01M | $32.45M | $28.32M | $30.38M | $40.48M | $32.28M |
| **Financing Cash Flow** | $87.26M | $65K | -$1.12M | -$4.59M | $115K | $0 | $189K | $0 |
| **Net Change in Cash** | -$754K | -$7.15M | -$4.07M | -$3.08M | $1.47M | -$4.33M | $8.03M | -$7.42M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -283.6% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -246.0% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -63.4% | -49.2% | -66.8% | -54.6% | -43.6% | -38.2% | -- |
| Return on Assets (ROA) | -47.4% | -38.5% | -53.0% | -43.9% | -34.9% | -32.2% | -52.2% |
| Current Ratio | 6.93x | 7.32x | 7.16x | 7.98x | 7.98x | 12.07x | 4.62x |
| Quick Ratio | 6.73x | 6.77x | 6.96x | 0.76x | 1.36x | 11.85x | 4.52x |
| Debt to Equity | 0.18x | 0.13x | 0.10x | 0.11x | 0.13x | 0.01x | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -615.2% | -681.0% | -789.3% | -283.6% |
| **Net Profit Margin** | -- | -- | -- | -- | -555.8% | -605.9% | -834.5% | -246.0% |
| Return on Equity (ROE) | -69.1% | -97.1% | -68.0% | -63.4% | -59.0% | -59.3% | -75.9% | -49.2% |
| Return on Assets (ROA) | -52.4% | -64.8% | -49.1% | -47.4% | -45.6% | -46.3% | -58.4% | -38.5% |
| Current Ratio | 7.33x | 4.82x | 6.19x | 6.93x | 7.76x | 7.99x | 6.94x | 7.32x |
| Quick Ratio | 7.07x | 4.64x | 6.01x | 6.73x | 7.49x | 7.35x | 6.48x | 6.77x |
| Debt to Equity | 0.18x | 0.26x | 0.21x | 0.18x | 0.16x | 0.15x | 0.14x | 0.13x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -- | -- | -100.0% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -579.5% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -578.6% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
